Comprehensive Assessment of Genetic and Molecular Features Predicting Outcome in Patients With Chronic Lymphocytic Leukemia: Results From the US Intergroup Phase III Trial E2997 - Grever, Michael R.; Lucas, David M.; Dewald, Gordon W.; Neuberg, Donna S.; Reed, John C.; Kitada, Shinichi; Flinn, Ian W.; Tallman, Martin S.; Appelbaum, Frederick R.; Larson, Richard A.; Paietta, Elisabeth; Jelinek, Diane F.; et al. (Journal of clinical oncology, 2007)
Keywords: ADP-ribosyl Cyclase 1 - analysis; Adult; Aged; Aged, 80 and over; Apoptosis; Biological and medical sciences; Chromosome Aberrations; Female; Genes, p53; Hematologic and hematopoietic diseases; Humans; Immunoglobulin Heavy Chains - genetics; Immunoglobulin Variable Region - genetics; Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy; Leukemia, Lymphocytic, Chronic, B-Cell - genetics; Leukemia, Lymphocytic, Chronic, B-Cell - mortality; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; Male; Medical sciences; Middle Aged; Mutation; Prospective Studies; Tumors; ZAP-70 Protein-Tyrosine Kinase - analysis; Phase III trial; Human; Chemotherapy; Chronic lymphocytic leukemia; Cancerology; Prognosis; Treatment; Genetics; Malignant hemopathy